Techniques for parametric imaging

Biomedical Information Technology

Volumn , Issue , 2008, Pages 137-163

  Dagan Feng, David ^a,b,c,d   Wen, Lingfeng ^b   Eberl, Stefan ^b,c  

^a Biomedical and Multimedia Information Technology (BMIT)   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; IMAGE RECONSTRUCTION; LEAST SQUARES APPROXIMATIONS; MEDICAL IMAGING; NONINVASIVE MEDICAL PROCEDURES; PHYSIOLOGY; SPECTRUM ANALYSIS;

BIOCHEMICAL PROCESS; FUNCTIONAL PARAMETERS; IMAGE-DERIVED INPUT FUNCTIONS; LINEAR LEAST-SQUARES METHOD; NONINVASIVE METHODS; NONINVASIVE VISUALIZATION; QUANTITATIVE ESTIMATES; REFERENCE TISSUE MODEL;

PARAMETER ESTIMATION;

EID: 84882483238     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373583-6.50010-4     Document Type: Chapter

References (121)

1. Beyer T. A combined PET/CT scanner for clinical oncology. J. Nucl. Med. 2000, 41:1369-1379.
2. Karp J.S. BeneWt of time-of-Xight information for whole-body FDG PET. J. Nucl. Med. 2006, 47(suppl):529.
3. Almeida P. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: Comparison with carbon-11 epidepride and positron emission to. Eur. J. Nucl. Med. 1999, 26:1580-1588.
4. Silverman D.H.S. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: Comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J. Nucl. Med. 2004, 45:597-607.
5. Pekar J.J. A brief introduction to functional MRI. IEEE Eng. Med. Biol. Mag. 2006, 35:24-26.
6. Burger C., Buck A. Requirements and implementation of a Xexible kinetic modeling tool. J. Nucl. Med. 1997, 138:1818-1823.
7. Huang S.-C., Phelps M.E. Principles of tracer kinetic modeling in positron emission tomography and autoradiography. Positron Emmission Tomography and Autoradiography: Principles and Applications for the Brain and Heart 1986, 287-346. Raven Press.
8. Huang S.-C. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am. J. Physiol. 1980, 238:E69-E82.
9. Eberl S. Quantitative Physiological Parameter Estimation from Dynamic Single Photon Emission Computed Tomography (SPECT) 2000, University of New South Wales.
10. Zhang Z. Parameter estimation techniques: A tutorial with application to conic Wtting. Image and Vision Computing Journal 1997, 15:59-76.
11. Kety S.S. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol. Rev. 1951, 3:1-41.
12. Kety S.S. Measurement of local blood Xow by the exchange of an inert, diVusible substance. Methods Med. Res. 1960, 8:228-236.
13. Johnson M.L., Faunt L.M. Parameter-estimation by least-squares methods. Methods Enzymol. 1992, 210:1-37.
14. Fletcher R. Practical Methods of Optimization 1981, John Wiley & Sons, Sydney, Australia.
15. Press W.H. Numerical Recipes in C: The Art of Scientific Computing 1992, Cambridge University Press. 2nd ed.
16. Carson R.E. Parameter estimation in positron emission tomography. Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart 1986, 347-390. Raven Press.
17. Ichise M., Meyer J.H., Yonekura Y. An introduction to PET and SPECT neuroreceptor quantiWcation models. J. Nucl. Med. 2001, 42:755-763.
18. Lammertsma A.A. Accuracy of the oxygen-15 steady state technique for measuring rCBF and rCMRO2. J. Cereb. Blood Flow Metab. 1981, 1(suppl):S3-S4.
19. Meyer E., Yamamoto Y.L. The requirement for constant arterial radioactivity in the C15O2 steady-state blood Xow model. J. Nucl. Med. 1984, 25:455-460.
20. Correia J.A. Analysis of some errors in the measurement of oxygen extraction and oxygen consumption by the equilibrium inhalation method. J. Cereb. Blood Flow Metab. 1985, 5:591-599.
21. Wienhard K. Measurement of glucose consumption using [18F]Xuorodeoxyglucose. Methods 2002, 27:218-225.
22. Reivich M. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]Xuorodeoxyglucose and [11C]deoxygluco. J. Cereb. Blood Flow Metab. 1985, 5:179-192.
23. Hutchins G.D. Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs with particular application to ischemia. J. Cereb. Blood Flow Metab. 1984, 4:35-40.
24. Brooks R.A. Alternative formula for glucose utilization using labeled deoxyglucose. J. Nucl. Med. 1982, 23:533-539.
25. Clark C.M., Grochowski E.W., Ammann W. A method for comparing diVerent procedures of estimating regional glucose metabolism using Xuorine-18-Xuorodeoxyglucose. J. Nucl. Med. 1992, 33:157-160.
26. Rhodes C.G. vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann. Neurol. 1983, 14:614-626.
27. Huang S.-C. Anatomy of SUV. Nucl. Med. Biol. 2000, 27:643-646.
28. Lindholm P. InXuence of the blood glucose concentration on FDG uptake in cancer-A PET study. J. Nucl. Med. 1993, 34:1-6.
29. Keyes J.W. SUV: Standard uptake or silly useless value. J. Nucl. Med. 1995, 36:1836-1839.
30. Zasadny K.R., Wahl R.L. Standardized uptake values of normal tissues at PET with 2-[Xuorine-18]-Xuoro-2-deoxy-D-glucose: Variations with body weight and a method for correction. Radiology 1993, 189:847-850.
31. Kim C.K. Standardized uptake values of FDG: Body surface area correction is preferable to body weight correction. J. Nucl. Med. 1994, 35:164-167.
32. Huang S.-C., Carson R.E., Phelps M.E. Measurement of local blood Xow and distribution volume with short-lived isotopes: a general input technique. J. Cereb. Blood Flow Metab. 1982, 2:99-108.
33. Huang S.-C. Quantitative measurement of local cerebral blood Xow in humans by positron computed tomography and 15O-water. J. Cereb. Blood Flow Metab. 1983, 3:141-153.
34. Feng D. Techniques for functional imaging. Medical Imaging Systems Techniques and Applications 1997, 85-145. Gordon and Breach Science Publishers. C.T. Leondes, D. Feng (Eds.).
35. Alpert N.M. Strategy for the measurement of regional cerebral blood Xow using short-lived tracers and emission tomography. J. Nucl. Med. 1984, 4:28-34.
36. Carson R.E., Huang S.-C., Green M.V. Weighted integration method for local cerebral blood Xow measurements with positron emission tomography. J. Cereb. Blood Flow Metab. 1986, 6:245-258.
37. Yokoi T. A new approach of weighted integration technique based on accumulated image using dynamic PET and H2 15O. J. Cereb. Blood Flow Metab. 1991, 11:492-501.
38. Iida H. Effect of real-time weighted integration system for rapid calculation of functional images in clinical positron emission tomography. IEEE Trans. Med. Imaging 1995, 14:116-121.
39. Feng D. An evaluation of the algorithms for determining local cerebral metabolic rates of glucose using positron emission tomography dynamic data. IEEE Trans. Med. Imaging 1995, 14:697-710.
40. Meikle S.R. Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study, Cancer Chemother. Pharmacol. 1998, 42:183-193.
41. Cunningham V.J., Jones T. Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab. 1993, 13:15-23.
42. Turkheimer F. The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]Xuorodeoxyglucose: Theory, implemen. J. Cereb. Blood Flow Metab. 1994, 14:406-422.
43. Matthews J. The direct calculation of parametric images from dynamic PET data using maximumlikelihood iterative reconstruction. Physics Med. Biol. 1997, 42:1155-1173.
44. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983, 3:1-7.
45. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data Generalizations. J. Cereb. Blood Flow Metab. 1985, 5:584-590.
46. Wienhard K. Estimation of local cerebral glucose utilization by positron emission tomography of [18F] 2-Xuoro-2-deoxy-D-glucose: A critical appraisal of optimization proc. J. Cereb. Blood Flow Metab. 1985, 5:115-125.
47. Logan J. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
48. Logan J. Effects of blood Xow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J. Cereb. Blood Flow Metab. 1994, 14:995-1010.
49. Yokoi T. A new graphic plot analysis for cerebral blood Xow and partition coeYcient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-1. J. Nucl. Med. 1993, 34:498-505.
50. Heiss W.D. Atlas of Positron Emission Tomography of the Brain 1985, Springer-Verlag.
51. Feng D. An unbiased parametric imaging algorithm for nonuniformly sampled biomedical system parameter estimation. IEEE Trans. Med. Imaging 1996, 15:512-518.
52. Feng D., Wang Z., Huang S.-C. A study on statistically reliable and computationally eYcient algorithms for generating local cerebral blood Xow parametric image with positron emission tomog. IEEE Trans. Med. Imaging. 1993, 12:182-188.
53. Chen K. Generalized linear least-squares method for fast generation of myocardial blood Xow parametric images with N-13 ammonia PET. IEEE Trans. Med. Imaging. 1998, 17:236-243.
54. Choi H.-C. Fast parametric imaging algorithm for dual-input biomedical system parameter estimation. Comput. Methods Programs Biomed. 2006, 81:49-55.
55. Wen L. Improved generalized linear least squares algorithms for generation of parametric images from dynamic SPECT. J. Nucl. Med. 2006, 47(suppl):61.
56. Choi H.-C. Methods for improving reliability of GLLS for parametric image generation 2006, Reims.
57. Wen L. Effect of reconstruction and Wltering on kinetic parameter estimation bias and reliability for dynamic SPECT: A simulation study. IEEE Trans. Nucl. Sci. 2005, 52:69-78.
58. Wen L., Eberl S., Feng D. Enhanced parameter estimation with GLLS and the Bootstrap Monte Carlo method for dynamic SPECT 2006.
59. Kamasak M.E. Direct reconstruction of kinetic parameters images from dynamic PET data. IEEE Trans. Med. Imaging 2005, 24:636-650.
60. Huesman R.H. Kinetic parameter estimation from SPECT cone-beam projection measurements. Physics Med. Biol. 1998, 43:973-982.
61. Kadrmas D.J., Gullberg G.T. A maximum a posteriori algorithm for the reconstruction of dynamic SPECT data 1998.
62. Gullberg G.T. Dynamic cardiac single-photon emission computed tomography. Nuclear Cardiology: State of the Art and Future Directions 1998, 137-187. Mosby-Year Book Inc., France.
63. Phelps M.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-Xuoro-2-deoxy-D-glucose: Validation of method. Ann. Neurol. 1979, 6:371-388.
64. Gambhir S.S. Simple noninvasive quantiWcation method for measuring myocardial glucose utilization in humans employing positron emission tomography and Xuorine-18 deoxygluc. J. Nucl. Med. 1989, 30:359-366.
65. Iida H. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J. Nucl. Med. 1992, 33:1669-1677.
66. Lin K.-P. Correction of spillover radioactivities for estimation of the blood time-activity curve from the image LV chamber in cardiac dynamic FDG PET studies. Physics Med. Biol. 1995, 40:629-642.
67. Wahl L.D., Asselin M.C., Nahmias C. Regions of interest in the venous sinuses as input functions for quantitative PET. J. Nucl. Med. 1999, 40:1666-1675.
68. Ohtake T. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J. Nucl. Med. 1991, 32:1432-1438.
69. Germano G. Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J. Nucl. Med. 1992, 33:613-620.
70. Dhawan V. Quantitative brain FDG/PET studies using dynamic aortic imaging. Physics Med. Biol. 1994, 39:1475-1487.
71. Chen K. Noninvasive quantiWcation of the cerebral metabolic rate for glucose using positron emission tomography, 18F-Xuoro-2-deoxyglucose, the Patlak method, and an i. J. Cereb. Blood Flow Metab. 1998, 18:716-723.
72. Liptrot M. Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling. Neuroimage 2004, 21:483-493.
73. Feng D. A technique for extracting physiological parameters and the required input function simultaneously from PET image measurements: Theory and simulation study. IEEE Trans. Inf. Technol. Biomed. 1997, 1:243-254.
74. Wong K.P. Simultaneous estimation of physiological parameters and the input function-In vivo PET data. IEEE Trans. Inf. Technol. Biomed. 2001, 5:67-76.
75. Logan J. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
76. Gunn R.N. Parametric imaging of ligand-receptor binding in PET using a simpliWed reference region model. Neuroimage 1997, 6:279-287.
77. Lammertsma A.A., Hume S.P. SimpliWed reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
78. Wu Y., Carson R.E. Noise reduction in the simpliWed reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.
79. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl. Med. Biol. 2000, 27:661-670.
80. Ichise M. Noninvasive quantiWcation of dopamine D2 receptors with iodine-123-IBF SPECT. J. Nucl. Med. 1996, 37:513-520.
81. Ichise M. Linearized reference tissue parametric imaging methods: Application to [11C]DASB positron emission tomography studies of the serotonin transporter in human br. J. Cereb. Blood Flow Metab. 2003, 23:1096-1112.
82. Takikawa S. Noninvasive quantitative Xuorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993, 188:131-136.
83. Eberl S. Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur. J. Nucl. Med. 1997, 24:299-304.
84. Wakita K. SimpliWcation for measuring input function of FDG PET: investigation of 1-point blood sampling method. J. Nucl. Med. 2000, 41:1484-1490.
85. Tsuchida T. Noninvasive measurement of cerebral metabolic rate of glucose using standardized input function. J. Nucl. Med. 1999, 40:1441-1445.
86. Shiozaki T. Noninvasive estimation of FDG input function for quantiWcation of cerebral metabolic rate of glucose: optimization and multicenter evaluation. J. Nucl. Med. 2000, 41:1612-1618.
87. Feng D., Huang S.-C., Wang X. Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. Int. J. Biomed. Comput. 1993, 32:95-110.
88. Feng D. Information technology applications in biomedical functional imaging. IEEE Trans. Inf. Technol. Biomed. 1999, 3:221-230.
89. Feng D., Wang X., Yan H. A computer simulation study on the input function sampling schedules in tracer kinetic modeling with positron emission tomography (PET). Comput. Methods Programs Biomed. 1994, 45:175-186.
90. Hirao K. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood Xow SPECT. Neuroimage 2005, 28:1014-1021.
91. Knowlton R.C. Ictal SPECT analysis in epilepsy-Subtraction and statistical parametric mapping techniques. Neurology 2004, 63:10-15.
92. Mountz J.M., Liu H.G., Deutsch G. Neuroimaging in cerebrovascular disorders: measurement of cerebral physiology after stroke and assessment of stroke recovery. Semin. Nucl. Med. 2003, 33:56-76.
93. Shuke N. Demonstration of positional posterior circulation cerebral ischemia on cerebral blood Xow SPECT. Clin. Nucl. Med. 2001, 26:559-560.
94. Iida H. Noninvasive quantiWcation of cerebral blood Xow using oxygen-15-water and a dual-PET system. J. Nucl. Med. 1998, 38:1789-1798.
95. Sivaratnam D.A., Bonow R.O., KalV V. Assessment of myocardial viability in dysfunctional myocardium. Nuclear Medicine in Clinical Diagnosis and Treatment 2004, 1159-1170. Churchill Livingstone. 3rd ed. P.J. Ell, S.S. Gambhir (Eds.).
96. Slart R.H.J.A. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int. J. Cardiovasc. Imaging 2006, 22.
97. Nuyts J. Three-dimensional correction for spillover and recovery of myocardial PET images. J. Nucl. Med. 1996, 37:767-774.
98. Mansoor M.R., Heller G.V. Gated SPECT imaging. Semin. Nucl. Med. 1999, 24:271-278.
99. Hattori N. Accuracy of a method using short inhalation of 15O-O2 for measuring cerebral oxygen extraction fraction with PET in healthy humans. J. Nucl. Med. 2004, 45:765-770.
100. Frackowiak R.S. Quantitative measurement of regional cerebral blood Xow and oxygen metabolism in man using 15O and positron emission tomography. J. Comput. Assist. Tomog. 1980, 4:727-736.
101. Lammertsma A.A., Jones T. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method. J. Cereb. Blood Flow Metab. 1983, 3:416-424.
102. Martin W.R., Powers W.J., Raichle M.E. Cerebral blood volume measured with inhaled C15O and positron emission tomography. J. Cereb. Blood Flow Metab. 1987, 7:421-426.
103. Mintun M.A. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J. Nucl. Med. 1984, 25:177-187.
104. Iida H., Jones T., Miura S. Modeling approach to eliminate the need to separate arterial plasma in oxygen-15 inhalation positron emission tomography. J. Nucl. Med. 1993, 34:1333-1340.
105. Shidahara M. Evaluation of a commercial PET tomography-based system for the quantitative assessment of rCBF, rOEF and rCMRO2 by using sequential administration of 15O-labe. Ann. Nucl. Med. 2002, 16:317-327.
106. Kudomi N. Rapid quantitative measurement of CMRO2 and CBF by dual administration of 15O-labled oxygen and water during a single PETscan-A validation study and error ana. J. Cereb. Blood Flow Metab. 2005, 25:1209-1224.
107. Brown M. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987, 76:687-696.
108. Armbrecht J.J. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation 1989, 80:864-872.
109. Ukkonen H. Use of [11C]acetate and [15O]O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infraction. Eur. J. Nucl. Med. 2001, 28:334-339.
110. Camici P.G. Positron emission tomography. Nuclear Medicine in Clinical Diagnosis and Treatment 2004, 1075-1091. Churchill Livingstone. 3rd ed. P.J. Ell, S.S. Gambhir (Eds.).
111. Iida H. Noninvasive quantiWcation of regional myocardial metabolic rate of oxygen by use of 15O2 inhalation and positron emission tomography: Theory, error analysis,. Circulation 1996, 94:792-807.
112. KelloV G.J., HoVman J.M., Johnson B. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 2005, 11:2785-2808.
113. Guo J. vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. J. Nucl. Med. 2004, 45:1334-1339.
114. Vansteenkiste J.F. Prognostic importance of the standardized uptake value on 18F-Xuoro-2-deoxyglucose-positron emission tomography scan in non-small-cell lung cancer: An analysi. J. Clin. Oncol. 1999, 17:3201-3206.
115. Brink I. Small cell lung cancer (SCLS): Glucose metabolism and prognostic signiWcance. J. Nucl. Med. 2006, 47(suppl):163-164.
116. Hoekstra C.J. Monitoring response to therapy in cancer using [18F]-2-Xuoro-2-deoxy-D-glucose and positron emission tomography: An overview of diVerent analytical methods. Eur. J. Nucl. Med. 2000, 27:731-743.
117. Passchier J. On the quantiWcation of [18F]MPPF binding to 5-HT1A receptors in the human brain. J. Nucl. Med. 2001, 42:1025-1031.
118. Heiss W.D., Herholz K. Brain receptor imaging. J. Nucl. Med. 2006, 47:302-312.
119. Waard A.van Measuring receptor occupancy with PET. Current Pharm. Des. 2000, 6:1593-1610.
120. Lee C.-M., Farde L. Using positron emission tomography to facilitate CNS drug development. Trends Pharmacol. Sci. 2006, 27:310-315.
121. Rowe C.C. Visual analysis of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. J. Nucl. Med. 2006, 47(suppl):75.